Perspective Therapeutics (CATX) Other Non-Current Assets (2011 - 2026)

Perspective Therapeutics (CATX) posted Other Non-Current Assets of $490000.0 for Q1 2026, up 0.82% sequentially from $486000.0 in Q4 2025.

Perspective Therapeutics (CATX) Other Non-Current Assets (2011 - 2026) Analysis & Trends

Perspective Therapeutics has reported Other Non-Current Assets for 16 years, with the latest figure at $490000.0 in Q1 2026.

Quarterly Other Non-Current Assets changed N/A year-over-year to $490000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $490000.0 (changed N/A YoY) and the FY2025 annual result came in at $486000.0, up 20.0% from the prior year.
Other Non-Current Assets climbed to $490000.0 in Q1 2026 per CATX's latest filing, from $486000.0 in the prior quarter.
Over five years, Other Non-Current Assets peaked at $490000.0 in Q1 2026 and troughed at $175000.0 in Q4 2022.
A 5-year average of $289200.0 and a median of $182000.0 in 2022 frame the typical range for Other Non-Current Assets.
The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 178.29% in 2023, then retreated 16.84% in 2024.
Over 5 years, Other Non-Current Assets stood at $175000.0 in 2022, then surged by 178.29% to $487000.0 in 2023, then dropped by 16.84% to $405000.0 in 2024, then rose by 20.0% to $486000.0 in 2025, then increased by 0.82% to $490000.0 in 2026.
According to Business Quant data, Other Non-Current Assets over the past three periods registered $490000.0, $486000.0, and $438000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Abbott Laboratories	199.49 Bn	193.88 Bn	7.27 Bn	-
2	Stryker	127.80 Bn	124.32 Bn	4.50 Bn	3.23 Bn
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn	4.15 Bn
4	Boston Scientific	73.58 Bn	73.04 Bn	3.85 Bn	45.22 Bn
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn	616.40 Mn
6	Dexcom	34.34 Bn	32.39 Bn	830.00 Mn	273.70 Mn
7	GE HealthCare Technologies	33.76 Bn	31.66 Bn	2.18 Bn	2.25 Bn
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn	148.78 Mn
9	Steris	23.07 Bn	22.59 Bn	684.20 Mn	215.10 Mn
10	Perspective Therapeutics	386.08 Mn	386.08 Mn	-	509,000.00

Download Data